Subjective but not objective numeracy influences willingness to pay for BRCA1/2 genetic testing
A positive test result for BRCA1/2 gene mutation is a substantial risk factor for breast and ovarian cancer.However, testing is not always covered by insurance, even for high risk women.Variables affecting willingness to pay (WTP) have implications for clinic-based and direct-to-consumer testing.The relative impact of objective and subjective numer